Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EU mergers and takeovers (Oct 23)

Wed, 23rd Oct 2013 11:17

BRUSSELS, Oct 23 (Reuters) - The following are mergers underreview by the European Commission and a brief guide to the EUmerger process:

APPROVALS AND WITHDRAWALS

-- U.S. group Koch Industries to acquireelectronic components maker Molex (approved Oct. 23)

NEW LISTINGS

-- Japan's Suntory Beverage & Food Ltd to buyBritish drugmaker GlaxoSmithKline Plc's Lucozade andRibena brands (notified Oct. 22/deadline Nov. 27)

-- U.S. bank Goldman Sachs to acquire sole control ofBritish motor insurer Hastings Insurance Group (notified Oct.21/deadline Nov. 26/simplified)

EXTENSIONS AND OTHER CHANGES

None

FIRST-STAGE REVIEWS BY DEADLINE

OCT 24

-- Private equity firm Triton to buy telecoms and energyinfrastructure builder Alpine Energie from Spanish constructiongroup FCC (notified Sept. 19/deadline Oct.24/simplified)

OCT 25

-- Private equity firm CVC Capital Partners to buy some ofCampbell Soup Co's brands (notified Sept. 20/deadlineOct. 25)

OCT 29

-- Dutch dredger Boskalis and investment companyReggeborgh to acquire joint control of subsea power cablessupplier Visser & Smit Marine Contracting B.V. which is nowsolely controlled by Reggeborgh (notified Sept. 24/deadliineOct. 29)

NOV 4

-- Private investment firm TPG and CaixaBank S.A. to set upa property joint venture by acquiring the business of CaixaBankunit Servihabitat (notified Sept. 27/deadline Nov. 4/simplified)

-- Piper Verlag GmbH to acquire a 50 percent stake in thejoint venture G+J RBA GmbH & Co which is now solely owned byGerman publisher Gruner + Jahr AG & Co (notified Sept.27/deadline Nov. 4/simplified)

NOV 5

-- Switzerland-based INEOS and Belgian chemicals companySolvay to form a joint venture (notified Sept.16/deadline extended to Nov. 5 from Oct. 21 after Solvay offeredconcessions)

-- British telecoms operator Vodafone to buy aminority stake in Vodafone Omnitel N.V. from U.S. peer VerizonCommunications Inc (notified Sept. 30/deadline Nov.5/simplified)

NOV 6

-- South African furniture retailer Steinhoff InternationalHoldings to acquire electrical appliances retailerRudolf Leiner Gesellschaft m.b.H. and LKMBeteiligungsgesellschaft m.b.H. (notified Oct. 1/deadline Nov.6/simplified)

-- Hutchison 3G UK to acquire Telefonica Ireland,a unit of Spanish telecoms provider Telefonica (notified Oct. 1/deadline Nov. 6)

NOV 12

-- U.S. maker of scientific and laboratory equipment ThermoFisher Scientific to buy genetic testing equipment makerLife Technologies (notified Oct. 7/deadline Nov. 12)

NOV 14

-- Japanese trading house Mitsui & Co, IskandarInvestment Berhad (IIB) which is majority owned by Malaysianstate investor Khazanah Nasional Berhad, andinvestment company UWI Capital One to acquire joint control ofMedini Iskandar Malaysia Sdn Bhd, which is now jointlycontrolled by IIB and UWI (notified Oct. 9/deadline Nov.14/simplified)

NOV 18

-- U.S. asset management fund Ares Management LLC andCanada's Ontario Teachers Pension Plan Board to acquire jointcontrol of U.S. building products company CPG International LLC,which is now solely controlled by Ares (notified Oct.11/deadline Nov. 18/simplified)

-- Norwegian telecoms operator Telenor to take astake in a venture owned by Norwegian publishing house Schibsted and Singapore Press Holdings, and also to set up ajoint venture with Schibsted focusing on South American business(notified Oct. 11/deadline Nov. 18/simplified)

-- Parkwind, which is an investment vehicle of Belgiansupermarket chain Colruyt Group, and special purposevehicle Summit Renewable Energy, which is owned by Japan'sSumitomo Corp, to acquire joint control of wind farmoperator Belwind 1, which is now solely owned by SummitRenewable Energy (notified Oct. 11/deadline Nov. 18/simplified)

-- French luxury goods company LVMH to buy an 80percent stake in Italian luxury cashmere clothing brand LoroPiana (notified Oct. 11/deadline Nov. 18/simplified)

NOV 21

-- Czech energy company EPH to acquire Slovakian powerdistributor Stredoslovenska Energetika (SSE) from Frenchstate-controlled utility EDF (notified Oct. 15/deadlineNov. 21)

NOV 25

-- Private equity investor 3i Group to acquire sole controlof ferry operator Scandferries Holdings which is now jointlycontrolled by 3i and ACP Affiliates (notified Oct. 18/deadlineNov. 25/simplified)

MARCH 10

-- Swiss cement maker Holcim to buy some ofMexican peer Cemex's assets in Germany (notified Sept. 3/dateline extended to March 10 from Oct. 22after the Commission opened an in-depth investigation into thedeal)

GUIDE TO EU MERGER PROCESS

DEADLINES:

The European Commission has 25 working days after a deal is filed for a first-stage review. It may extend that by 10 workingdays to 35 working days, to consider either a company's proposedremedies or an EU member state's request to handle the case.

Most mergers win approval but occasionally the Commission opens a detailed second-stage investigation for up to 90 additional working days, which it may extend to 105 working days.

SIMPLIFIED:

Under the simplified procedure, the Commission announces theclearance of uncontroversial first-stage mergers without givingany reason for its decision. Cases may be reclassified asnon-simplified -- that is, ordinary first-stage reviews -- untilthey are approved.

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.